Articles
-
Oct 28, 2024 |
trialsjournal.biomedcentral.com | Mary Lou |James A M |Diabetes Victoria
The study will be conducted in Australia, using primarily online methods. Participants will use their own device(s) (i.e. laptop, desktop, smartphone, and/or tablet computer) from a physical location of their choice. Platform O, a Deakin University owned and developed e-research platform, will be used to host the online intervention and automate data collection and email reminder systems.
-
May 23, 2023 |
trialsjournal.biomedcentral.com | Mary Lou |van Bruggen |Diabetes Victoria |Le Gautier
DesignThis study uses a hybrid type I effectiveness-implementation trial design [26] to test the effectiveness of LISTEN in a two-arm pragmatic, individual-level randomised controlled trial (RCT). We will simultaneously gather information on any barriers to, and facilitators of, implementation [26]. LISTEN (intervention) will be compared to usual care (comparison group), in terms of its impact on diabetes distress at 8 weeks (T1) and 6 months (T2) post-randomisation.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →